Presentation of the second quarter 2016 results and Hexvix/Cysview update

Photocure will present its second quarter report on Tuesday 23 August 2016 at Hotel Continental, Oslo, Norway.

Additionally, Dr. Daneshmand will provide an update on Hexvix/Cysview following the new bladder cancer guidelines from American Urological Association (AUA) and the Society of Urological Oncology (SUO), where enhanced cystoscopy including Blue Light Cystoscopy with Hexvix/ Cysview is recommended.

Agenda (CET)

  • 08:30 – 09:05 Q2 presentation by Kjetil Hestdal, President and CEO, and Erik Dahl, CFO.
    The presentation will be held in Norwegian.
  • 09:05 – 09:15 Break
  • 09:15 – 09:45 Dr. Sia Daneshmand, MD, Associate Professor of Urology (Clinical Scholar); Director of Urologic Oncology, Director of Research and Fellowship Director, USC Institute of Urology at University of Southern California, Los Angeles, USA.
    The presentation will be held in English.
  • 09:45 – 10:00 Ambaw Bellete, President, Photocure Inc. and Head, US Commercial Operations.
    The presentation will be held in English.

A light snack will be served from 08:00. 

The presentations will be publicly available at www.photocure.com.

Photocure will additionally host an audio webcast and conference call (http://webtv.hegnar.no/presentation.php?webcastId=36207441 ) the same day in English at 17:00 CET / 16:00 GMT / 12:00 EST.

Please join the event conference 5-10 minutes prior to the start time using the number and confirmation code below:

  • NORWAY:       +47 2100 2607
  • UK:                  +44(0)203 043 2002
  • USA:                +1 719 325 4936

Confirmation code: 6357841

It is possible to listen to a replay of the conference call on the following numbers:

  • NORWAY         +47 2350 0077
  • UK                   +44 (0)207 984 7568
  • USA                 +1 719 457 0820

Confirmation code: 6357841

Please register your attendance to the presentations at Photocure by Monday 22 August.
Contact person: Grete Faye-Schjøll (e-mail: gfs@photocure.no / phone +47 22 06 22 10 / fax +47 22 06 22 18).